- Home
- Publications
- Publication Search
- Publication Details
Title
Liquid biopsies: Potential and challenges
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-07-19
DOI
10.1002/ijc.33217
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis
- (2020) Richard Y. Ebright et al. SCIENCE
- The biology, function, and biomedical applications of exosomes
- (2020) Raghu Kalluri et al. SCIENCE
- Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer
- (2020) Huiyan Luo et al. Science Translational Medicine
- Deciphering cancer clues from blood
- (2020) Ning Ma et al. SCIENCE
- Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding
- (2019) Sofia Gkountela et al. CELL
- Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility
- (2019) Klaus Pantel et al. CLINICAL CHEMISTRY
- Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers
- (2019) Maria Panagopoulou et al. ONCOGENE
- Liquid biopsy and minimal residual disease — latest advances and implications for cure
- (2019) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Neutrophils escort circulating tumour cells to enable cell cycle progression
- (2019) Barbara Maria Szczerba et al. NATURE
- Circulating tumor cell count from a blood sample for colorectal cancer (CRC) prevention: A 627-patient prospective study.
- (2019) Wen-Sy Tsai et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen receptor expression in circulating tumor cells of patients with metastatic breast cancer
- (2019) Ingeborg E. de Kruijff et al. INTERNATIONAL JOURNAL OF CANCER
- Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence
- (2019) R. Charles Coombes et al. CLINICAL CANCER RESEARCH
- Genome-wide cell-free DNA fragmentation in patients with cancer
- (2019) Stephen Cristiano et al. NATURE
- Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?
- (2019) P Hofman et al. ANNALS OF ONCOLOGY
- ESR1 mutations in breast cancer
- (2019) Derek Dustin et al. CANCER
- Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer
- (2019) Fei Ma et al. INTERNATIONAL JOURNAL OF CANCER
- Evolution of the Liquid Biopsy in Metastatic Prostate Cancer
- (2019) Jose G. Moreno et al. UROLOGY
- Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells
- (2019) Yu-Heng Cheng et al. Nature Communications
- EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients
- (2019) Heather Scharpenseel et al. Scientific Reports
- Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples
- (2019) Ana Vivancos et al. Scientific Reports
- Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
- (2019) Melanie Janning et al. Cancers
- Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)
- (2019) Hench et al. Cancers
- Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays
- (2019) Joanna Budna-Tukan et al. Cancers
- Prognostic Significance of TWIST1, CD24, CD44, and ALDH1 Transcript Quantification in EpCAM-Positive Circulating Tumor Cells from Early Stage Breast Cancer Patients
- (2019) Areti Strati et al. Cells
- The Detection and Morphological Analysis of Circulating Tumor and Host Cells in Breast Cancer Xenograft Models
- (2019) Cleris et al. Cells
- Epithelial keratins: Biology and implications as diagnostic markers for liquid biopsies
- (2019) Stefan Werner et al. MOLECULAR ASPECTS OF MEDICINE
- Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer
- (2019) Simon A. Joosse et al. CLINICAL CHEMISTRY
- Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work Flows
- (2019) Rita Lampignano et al. CLINICAL CHEMISTRY
- High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
- (2019) Pedram Razavi et al. NATURE MEDICINE
- High ctDNA molecule numbers relate with poor outcome in advanced ER+, HER2− postmenopausal breast cancer patients treated with everolimus and exemestane
- (2019) Dinja T. Kruger et al. Molecular Oncology
- Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel
- (2019) Vera Constâncio et al. Clinical Epigenetics
- Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy
- (2018) Y S Li et al. ANNALS OF ONCOLOGY
- Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)
- (2018) Mark Jesus M. Magbanua et al. CLINICAL CANCER RESEARCH
- Change in Topoisomerase 1–Positive Circulating Tumor Cells Affects Overall Survival in Patients with Advanced Breast Cancer after Treatment with Etirinotecan Pegol
- (2018) Hope S. Rugo et al. CLINICAL CANCER RESEARCH
- In Situ Detection and Quantification of AR-V7, AR-FL, PSA, andKRASPoint Mutations in Circulating Tumor Cells
- (2018) Amin El-Heliebi et al. CLINICAL CHEMISTRY
- Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer
- (2018) Dana Wai Yi Tsui et al. EMBO Molecular Medicine
- Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
- (2018) Jason D. Merker et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
- (2018) Jing Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
- (2018) François-Clément Bidard et al. JNCI-Journal of the National Cancer Institute
- Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR -Mutated NSCLC
- (2018) Anna Buder et al. Journal of Thoracic Oncology
- Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse
- (2018) Karinna Almodovar et al. Journal of Thoracic Oncology
- Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance
- (2018) Meijun Du et al. LUNG CANCER
- PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
- (2018) Nicolas Guibert et al. LUNG CANCER
- Multigene Profiling of CTCs in mCRPC Identifies a Clinically Relevant Prognostic Signature
- (2018) Udit Singhal et al. MOLECULAR CANCER RESEARCH
- Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
- (2018) Christa Haldrup et al. Molecular Oncology
- Clinical utility of circulating non-coding RNAs — an update
- (2018) Simone Anfossi et al. Nature Reviews Clinical Oncology
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
- (2018) Ben O’Leary et al. Nature Communications
- Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
- (2018) Matti Annala et al. Cancer Discovery
- A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
- (2018) Igor Brikun et al. Clinical Epigenetics
- Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
- (2018) François-Clément Bidard et al. JNCI-Journal of the National Cancer Institute
- Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer
- (2018) Chelain R. Goodman et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Identification of a high-level MET amplification in CTCs and cfTNA of an ALK+ NSCLC patient developing evasive resistance to crizotinib
- (2018) Lars-Arne Berger et al. Journal of Thoracic Oncology
- The Clinical Impact of Comprehensive Genomic Testing of Circulating Cell-Free DNA in Advanced Lung Cancer
- (2018) Smadar Laufer-Geva et al. Journal of Thoracic Oncology
- A Digital RNA Signature of Circulating Tumor Cells Predicting Early Therapeutic Response in Localized and Metastatic Breast Cancer
- (2018) Tanya T. Kwan et al. Cancer Discovery
- Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes
- (2018) Alexandra Soler et al. Scientific Reports
- Association of Circulating Tumor Cells With Late Recurrence of Estrogen Receptor–Positive Breast Cancer
- (2018) Joseph Sparano et al. JAMA Oncology
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Single tube liquid biopsy for advanced non‐small cell lung cancer
- (2018) Sanne Wit et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating tumor cells with stemness and epithelial-to-mesenchymal transition features are chemoresistant and predictive of poor outcome in metastatic breast cancer
- (2018) Maria A Papadaki et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease
- (2018) Joshua Moss et al. Nature Communications
- Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease
- (2018) Annkathrin Hanssen et al. Cancers
- The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
- (2018) Massimo Cristofanilli et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Weekly cabazitaxel plus prednisone is effective and less toxic for ‘unfit’ metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial
- (2017) Miguel Ángel Climent et al. EUROPEAN JOURNAL OF CANCER
- Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns
- (2017) Bram De Laere et al. EUROPEAN UROLOGY
- Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair–deficient Prostate Cancer
- (2017) Matti Annala et al. EUROPEAN UROLOGY
- Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management
- (2017) Julie Vendrell et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages
- (2017) Meng Yang et al. Journal of Hematology & Oncology
- Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
- (2017) Alexander W Wyatt et al. JNCI-Journal of the National Cancer Institute
- Capture-Based Targeted Ultradeep Sequencing in Paired Tissue and Plasma Samples Demonstrates Differential Subclonal ctDNA-Releasing Capability in Advanced Lung Cancer
- (2017) Xiaowei Mao et al. Journal of Thoracic Oncology
- Validation of the SHOX2 / PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease
- (2017) Gunter Weiss et al. Journal of Thoracic Oncology
- Disseminated breast tumour cells: biological and clinical meaning
- (2017) Klaus Pantel et al. Nature Reviews Clinical Oncology
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy
- (2017) Lais Osmani et al. SEMINARS IN CANCER BIOLOGY
- Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients
- (2017) Luis León-Mateos et al. Oncotarget
- EMT circulating tumor cells detected by cell-surface vimentin are associated with prostate cancer progression
- (2017) Arun Satelli et al. Oncotarget
- Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients
- (2017) Marius Ilie et al. Oncotarget
- PSMA-PET for Lymph Node Detection in Recurrent Prostate Cancer: How do we use the Magic Bullet?
- (2017) Tobias Maurer et al. Theranostics
- Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer
- (2017) Alexander W Wyatt et al. JNCI-Journal of the National Cancer Institute
- Individualised multiplexed circulating tumour DNA assays for monitoring of tumour presence in patients after colorectal cancer surgery
- (2017) Sarah B. Ng et al. Scientific Reports
- Proteomic analysis of urinary extracellular vesicles from high Gleason score prostate cancer
- (2017) Kazutoshi Fujita et al. Scientific Reports
- Phenotypic diversity of circulating tumour cells in patients with metastatic castration-resistant prostate cancer
- (2016) Andrew S. McDaniel et al. BJU INTERNATIONAL
- Origins, structures, and functions of circulating DNA in oncology
- (2016) A. R. Thierry et al. CANCER AND METASTASIS REVIEWS
- Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer
- (2016) W. J. Janni et al. CLINICAL CANCER RESEARCH
- Paired High-Content Analysis of Prostate Cancer Cells in Bone Marrow and Blood Characterizes Increased Androgen Receptor Expression in Tumor Cell Clusters
- (2016) Anders Carlsson et al. CLINICAL CANCER RESEARCH
- Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells
- (2016) Tobias M. Gorges et al. CLINICAL CHEMISTRY
- Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer
- (2016) David Lorente et al. EUROPEAN UROLOGY
- Circulating Tumor Cells Detected in the Tumor-Draining Pulmonary Vein Are Associated with Disease Recurrence after Surgical Resection of NSCLC
- (2016) Phil A.J. Crosbie et al. Journal of Thoracic Oncology
- Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
- (2016) Malte Mohme et al. Nature Reviews Clinical Oncology
- Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
- (2016) Jeanne Tie et al. Science Translational Medicine
- Heterogeneous PSMA expression on circulating tumor cells - a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer
- (2016) Tobias M. Gorges et al. Oncotarget
- Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
- (2016) Howard I. Scher et al. JAMA Oncology
- Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)
- (2016) James L. Sherwood et al. PLoS One
- Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing
- (2016) Inga Medina Diaz et al. PLoS One
- Characterization of different CTC subpopulations in non-small cell lung cancer
- (2016) Annkathrin Hanssen et al. Scientific Reports
- Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
- (2016) Chiara Nicolazzo et al. Scientific Reports
- Improved detection of circulating tumor cells in non-metastatic high-risk prostate cancer patients
- (2016) Andra Kuske et al. Scientific Reports
- Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study
- (2015) U Bork et al. BRITISH JOURNAL OF CANCER
- Non-invasive sensitive detection of KRAS and BRAF mutation in circulating tumor cells of colorectal cancer patients
- (2015) Nur-Afidah Mohamed Suhaimi et al. Molecular Oncology
- Erratum: Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
- (2015) Giulia Siravegna et al. NATURE MEDICINE
- Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
- (2015) Gaia Schiavon et al. Science Translational Medicine
- Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
- (2015) Muhammed Murtaza et al. Nature Communications
- KRAS Genotypic Changes of Circulating Tumor Cells during Treatment of Patients with Metastatic Colorectal Cancer
- (2014) Aristea Kalikaki et al. PLoS One
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer
- (2013) C-Y Lu et al. BRITISH JOURNAL OF CANCER
- Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs
- (2013) Francesco Fabbri et al. CANCER LETTERS
- Plastin3 Is a Novel Marker for Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition and Is Associated with Colorectal Cancer Prognosis
- (2013) T. Yokobori et al. CANCER RESEARCH
- Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing
- (2013) E. Heitzer et al. CANCER RESEARCH
- Capture of Viable Circulating Tumor Cells in the Liver of Colorectal Cancer Patients
- (2013) E. Deneve et al. CLINICAL CHEMISTRY
- Circulating tumor cells in high-risk nonmetastatic colorectal cancer
- (2013) Paola Gazzaniga et al. TUMOR BIOLOGY
- Compartmental Differences of Circulating Tumor Cells in Colorectal Cancer
- (2012) Nuh N. Rahbari et al. ANNALS OF SURGICAL ONCOLOGY
- Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer
- (2012) C. Gasch et al. CLINICAL CHEMISTRY
- KRASandBRAFmutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
- (2012) Bianca Mostert et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer
- (2012) Jian-Mei Hou et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients
- (2012) Andreia de Albuquerque et al. Journal of Translational Medicine
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stereoscopic Digital Mammography: Improved Specificity and Reduced Rate of Recall in a Prospective Clinical Trial
- (2012) Carl J. D’Orsi et al. RADIOLOGY
- Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer
- (2011) Hisae Iinuma et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer
- (2011) Matthew G. Krebs et al. JOURNAL OF CLINICAL ONCOLOGY
- Circulating endothelial cells predict for response to bevacizumab-based chemotherapy in metastatic colorectal cancer
- (2010) Satoshi Matsusaka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Circulating tumour cells in cancer patients: challenges and perspectives
- (2010) Klaus Pantel et al. TRENDS IN MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search